Article Menu

Academic Editor

Richard P. Conway
Subscribe SciFeed
Recommended Articles
Related Info Links
- PubMed/Medline
- Google Scholar
More by Authors Links

/ajax/scifeed/subscribe

Article Views

Citations -

Printed Edition

A printed edition of this Special Issue is available at MDPI Books....

Altmetric Share Help Cite Discuss in SciProfiles

Need Help?

Support

Find support for a specific problem in the support section of our website.

Get Support

Feedback

Please let us know what you think of our products and services.

Give Feedback

Information

Visit our dedicated information section to learn more about MDPI.

Get Information

Open AccessFeature PaperArticle

Article Versions Notes

J. Clin. Med. 2024, 13(9), 2517; https://doi.org/10.3390/jcm13092517

Action	Date	Notes	Link
article xml file uploaded	25 April 2024 09:36 CEST	Original file	-
article xml uploaded.	25 April 2024 09:36 CEST	Update	https://www.mdpi.com/2077-0383/13/9/2517/xml
article pdf uploaded.	25 April 2024 09:36 CEST	Version of Record	https://www.mdpi.com/2077-0383/13/9/2517/pdf
article html file updated	25 April 2024 09:38 CEST	Original file	https://www.mdpi.com/2077-0383/13/9/2517/html

Cite

Export citation file: BibTeX | EndNote | RIS

MDPI and ACS Style

Calvo-Garcia, A.; Ramírez Herráiz, E.; Llorente Cubas, I.M.; Varas De Dios, B.; Benedí González, J.; Morell Baladrón, A.; García-Vicuña, R. The Real-World Effectiveness, Persistence, Adherence, and Safety of Janus Kinase Inhibitor Baricitinib in Rheumatoid Arthritis: A Long-Term Study. J. Clin. Med. 2024, 13, 2517. https://doi.org/10.3390/jcm13092517

AMA Style

Calvo-Garcia A, Ramírez Herráiz E, Llorente Cubas IM, Varas De Dios B, Benedí González J, Morell Baladrón A, García-Vicuña R. The Real-World Effectiveness, Persistence, Adherence, and Safety of Janus Kinase Inhibitor Baricitinib in Rheumatoid Arthritis: A Long-Term Study. Journal of Clinical Medicine. 2024; 13(9):2517. https://doi.org/10.3390/jcm13092517

Chicago/Turabian Style

Calvo-Garcia, Alberto, Esther Ramírez Herráiz, Irene María Llorente Cubas, Blanca Varas De Dios, Juana Benedí González, Alberto Morell Baladrón, and Rosario García-Vicuña. 2024. "The Real-World Effectiveness, Persistence, Adherence, and Safety of Janus Kinase Inhibitor Baricitinib in Rheumatoid Arthritis: A Long-Term Study" Journal of Clinical Medicine 13, no. 9: 2517. https://doi.org/10.3390/jcm13092517

APA Style

Calvo-Garcia, A., Ramírez Herráiz, E., Llorente Cubas, I. M., Varas De Dios, B., Benedí González, J., Morell Baladrón, A., & García-Vicuña, R. (2024). The Real-World Effectiveness, Persistence, Adherence, and Safety of Janus Kinase Inhibitor Baricitinib in Rheumatoid Arthritis: A Long-Term Study. Journal of Clinical Medicine, 13(9), 2517. https://doi.org/10.3390/jcm13092517

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Printed Edition

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI